Related references
Note: Only part of the references are listed.Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ3
Sribalaji Lakshmikanthan et al.
BLOOD (2011)
Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
P. Oesterlund et al.
BRITISH JOURNAL OF CANCER (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
Roberta Mazzieri et al.
CANCER CELL (2011)
VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast et al.
CANCER RESEARCH (2011)
Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab
Jan Pander et al.
CLINICAL CANCER RESEARCH (2011)
Multifaceted Role of Neuropilins in Cancer
S. Rizzolio et al.
CURRENT MEDICINAL CHEMISTRY (2011)
MicroRNA-mediated regulation of the angiogenic switch
Sudarshan Anand et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1
Tomasz Zygmunt et al.
DEVELOPMENTAL CELL (2011)
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patients
Wouter B. Nagengast et al.
EUROPEAN JOURNAL OF CANCER (2011)
Tumor exploits alternative strategies to achieve vascularization
Benedetta Bussolati et al.
FASEB JOURNAL (2011)
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
David A. Reardon et al.
FUTURE ONCOLOGY (2011)
Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism
Jiha Kim et al.
GENES & DEVELOPMENT (2011)
PET imaging of tumor angiogenesis in mice with VEGF-A-targeted 86Y-CHX-A-DTPA-bevacizumab
Tapan K. Nayak et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αvβ3-Integrin and αvβ5-Integrin Imaging Agent
Mark R. Battle et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PEST Motif Serine and Tyrosine Phosphorylation Controls Vascular Endothelial Growth Factor Receptor 2 Stability and Downregulation
Rosana D. Meyer et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Molecular control of endothelial cell behaviour during blood vessel morphogenesis
Shane P. Herbert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Efficient in vivo microRNA targeting of liver metastasis
C. Huynh et al.
ONCOGENE (2011)
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
L. Fang et al.
ONCOGENE (2011)
Contribution of cancer stem cells to tumor vasculogenic mimicry
Xiao-hong Yao et al.
PROTEIN & CELL (2011)
MT-MMPs as regulators of vessel stability associated with angiogenesis
Nor Eddine Sounni et al.
FRONTIERS IN PHARMACOLOGY (2011)
MicroRNA regulation by RNA-binding proteins and its implications for cancer
Marieke van Kouwenhove et al.
NATURE REVIEWS CANCER (2011)
Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
Elena I. Deryugina et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
The use of RGDGWK-lipopeptide to selectively deliver genes to mouse tumor vasculature and its complexation with p53 to inhibit tumor growth
Sanjoy Samanta et al.
BIOMATERIALS (2010)
Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
Wiem Lassoued et al.
CANCER BIOLOGY & THERAPY (2010)
MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis
Shih-Ting Cha et al.
CANCER RESEARCH (2010)
Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease
Sara Van de Veire et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Vascular microRNAs
Angelika Bonauer et al.
CURRENT DRUG TARGETS (2010)
Cancer associated fibroblasts (CAFs) in tumor microenvironment
Fei Xing et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Targeting of drugs and nanoparticles to tumors
Erkki Ruoslahti et al.
JOURNAL OF CELL BIOLOGY (2010)
Clinical Course of Advanced Non-Small-Cell Lung Cancer Patients Experiencing Hypertension During Treatment With Bevacizumab in Combination With Carboplatin and Paclitaxel on ECOG 4599
Suzanne E. Dahlberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
Monica Loi et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Cancer and Inflammation: Promise for Biologic Therapy
Sandra Demaria et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes
Fumitaka Takeshita et al.
MOLECULAR THERAPY (2010)
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
Suphansa Sawamiphak et al.
NATURE (2010)
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Lucia Ricci-Vitiani et al.
NATURE (2010)
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis
Yingdi Wang et al.
NATURE (2010)
Glioblastoma stem-like cells give rise to tumour endothelium
Rong Wang et al.
NATURE (2010)
Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells
Hideki Kobayashi et al.
NATURE CELL BIOLOGY (2010)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
A double agent in cancer: Deciphering macrophage roles in human tumors
Christiana Ruhrberg et al.
NATURE MEDICINE (2010)
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
Sudarshan Anand et al.
NATURE MEDICINE (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Kazuki N. Sugahara et al.
SCIENCE (2010)
Cancer associated fibroblasts in cancer pathogenesis
Omar E. Franco et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy?
Tamas A. Gonda et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Inhibition of Notch Signaling in Glioblastoma Targets Cancer Stem Cells via an Endothelial Cell Intermediate
Koos E. Hovinga et al.
STEM CELLS (2010)
Targeting integrins in malignant glioma
Ghazaleh Tabatabai et al.
TARGETED ONCOLOGY (2010)
Extracellular Matrix Proteins and Tumor Angiogenesis
N. E. Campbell et al.
JOURNAL OF ONCOLOGY (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors
Jason M. Butler et al.
NATURE REVIEWS CANCER (2010)
Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
Y. H. Park et al.
BRITISH JOURNAL OF CANCER (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Noninvasive Imaging of αVβ3 Function as a Predictor of the Antimigratory and Antiproliferative Effects of Dasatinib
Rebecca A. Dumont et al.
CANCER RESEARCH (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Integrin and Growth Factor Receptor Alliance in Angiogenesis
Payaningal R. Somanath et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2009)
Antimyeloangiogenic Therapy for Cancer by Inhibiting PIGF
Sonja Loges et al.
CLINICAL CANCER RESEARCH (2009)
Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Michael L. Maitland et al.
CLINICAL CANCER RESEARCH (2009)
Human Hepatocellular Carcinoma Tumor-derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial Cells
Yu-Quan Xiong et al.
CLINICAL CANCER RESEARCH (2009)
Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
John M. L. Ebos et al.
CLINICAL CANCER RESEARCH (2009)
AngiomiRs-Key regulators of angiogenesis
Shusheng Wang et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Peter Olson et al.
GENES & DEVELOPMENT (2009)
Endothelial cell differentiation of human breast tumour stem/progenitor cells
Benedetta Bussolati et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Antibody Library-based Tumor Endothelial Cells Surface Proteomic Functional Screen Reveals Migration-stimulating Factor as an Anti-angiogenic Target
Hai Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Targeting of Tumor Blood Vessels: A Phage-Displayed Tumor-Homing Peptide Specifically Binds to Matrix Metalloproteinase-2-Processed Collagen IV and Blocks Angiogenesis In vivo
Jan Mueller et al.
MOLECULAR CANCER RESEARCH (2009)
Low-dose metronomic cyclophosphamide combined with vascular disrupting therapy induces potent antitumor activity in preclinical human tumor xenograft models
Laura G. Daenen et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Endogenous inhibitors of angiogenesis A historical review
Domenico Ribatti
LEUKEMIA RESEARCH (2009)
An integrin αvβ3-c-Src oncogenic unit promotes anchorage-independence and tumor progression
Jay S. Desgrosellier et al.
NATURE MEDICINE (2009)
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
Benjamin J. Vakoc et al.
NATURE MEDICINE (2009)
Biomarkers of response and resistance to antiangiogenic therapy
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MicroRNAs: Opening a New Vein in Angiogenesis Research
Jason E. Fish et al.
SCIENCE SIGNALING (2009)
Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
Ayesha B. Alvero et al.
STEM CELLS (2009)
Trophic macrophages in development and disease
Jeffrey W. Pollard
NATURE REVIEWS IMMUNOLOGY (2009)
PET Imaging of Angiogenesis
Gang Niu et al.
PET CLINICS (2009)
Tumor-targeted interferon-α delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
Michele De Palma et al.
CANCER CELL (2008)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: Implications for antiangiogenic drugs as chemosensitizing agents
Yuval Shaked et al.
CANCER CELL (2008)
Besides adhesion: new perspectives of integrin functions in angiogenesis
Guido Serini et al.
CARDIOVASCULAR RESEARCH (2008)
Pathways Mediating Resistance to Vascular Endothelial Growth Factor - Targeted Therapy
Lee M. Ellis et al.
CLINICAL CANCER RESEARCH (2008)
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme
David A. Reardon et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Identification of a tumor-initiating stem cell population in human renal carcinomas
Benedetta Bussolati et al.
FASEB JOURNAL (2008)
A role for VEGF as a negative regulator of pericyte function and vessel maturation
Joshua I. Greenberg et al.
NATURE (2008)
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis
Christian Stockmann et al.
NATURE (2008)
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function
Natalie C. Jones et al.
NATURE MEDICINE (2008)
Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
Rulong Shen et al.
PLOS ONE (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis
Dingcheng Gao et al.
SCIENCE (2008)
Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography
S. Frenkel et al.
EYE (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Integrins in angiogenesis and lymphangiogenesis
Christie J. Avraamides et al.
NATURE REVIEWS CANCER (2008)
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Farbod Shojaei et al.
NATURE (2007)
The integrin - Growth factor receptor duet
Naved Alam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels
Christian Fischer et al.
CELL (2007)
Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis
Ganapati H. Mahabeleshwar et al.
CIRCULATION RESEARCH (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
Antiangiogenic strategies on defense: On the possibility of blocking rebounds by the tumor vasculature after chemotheraphy
Yuval Shaked et al.
CANCER RESEARCH (2007)
Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content
Marya F. McCarty et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Targeting of human renal tumor-derived endothelial cells with peptides obtained by phage display
Benedetta Bussolati et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia
Zhong Hua et al.
PLOS ONE (2006)
Macrophages regulate the angiogenic switch in a mouse model of breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2006)
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors
Yuval Shaked et al.
SCIENCE (2006)
Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin αvβ3 expression in man
Ambros J. Beer et al.
CLINICAL CANCER RESEARCH (2006)
Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures
B Bussolati et al.
EXPERIMENTAL CELL RESEARCH (2006)
VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells
M Grunewald et al.
CELL (2006)
MicroRNA function: Multiple mechanisms for a tiny RNA?
RS Pillai
RNA (2005)
Pathophysiological consequences of VEGF-induced vascular permeability
SM Weis et al.
NATURE (2005)
Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1
I Cascone et al.
JOURNAL OF CELL BIOLOGY (2005)
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
M Sund et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cell fusion-independent differentiation of neural stem cells to the endothelial lineage
AE Wurmser et al.
NATURE (2004)
Vascular zip codes in angiogenesis and metastasis
E Ruoslahti
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Robo4 is a vascular-specific receptor that inhibits endothelial migration
KW Park et al.
DEVELOPMENTAL BIOLOGY (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Get a ligand, get a life: integrins, signaling and cell survival
DG Stupack et al.
JOURNAL OF CELL SCIENCE (2002)
Tumor regression by targeted gene delivery to the neovasculature
JD Hood et al.
SCIENCE (2002)
Integrin and growth factor receptor crosstalk
BP Eliceiri
CIRCULATION RESEARCH (2001)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
DG Stupack et al.
JOURNAL OF CELL BIOLOGY (2001)
Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo
JS Xu et al.
JOURNAL OF CELL BIOLOGY (2001)
Direct cell adhesion to the angiopoietins mediated by integrins
TR Carlson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Preferential susceptibility of brain tumors to the antiangiogenic effects of an alpha v integrin antagonist
TJ MacDonald et al.
NEUROSURGERY (2001)
Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules
GE Davis et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Additional literature on vasculogenic mimicry not cited
P Shubik et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Vasculogenic mimicry and tumor angiogenesis
R Folberg et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
